TCRT

Healthcare Biotechnology

Alaunos Therapeutics, Inc.

$0.82

-0.06 -7.13% today

Price History

Not enough data

Key Stats

Market Cap

2.40M

Avg Volume

789,906

EPS

-$1.75

52W High

$4.59

52W Low

$0.82

Div. Yield

0.0%

Valuation

Forward P/E

-1.37

P/B Ratio

3.13

P/S Ratio

800.08

EV/EBITDA

-0.49

EV/Revenue

653.07

PEG Ratio

0.58

Margins

Gross Margin 0.0%

Operating Margin (135233.3%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(185.9%)

Return on Assets

(81.1%)

Liquidity & Leverage

Current Ratio

0.77

Quick Ratio

0.14

Total Cash

124,000

Total Debt

About

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.